Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 60 2020 021 484.4 |
| 96 | EP file number | EAKZ | 20 72 1374.5 |
| 86 | WO file number | WAKZ | PCT/US2020/027655 |
| 97 | EP publication number | EPN | 3953334 |
| 87 | WO publication number | WPN | 2020210613 |
| 54 | Designation/title | TI | NEUARTIGE SYNTHETISCHE MÖGLICHKEITEN ZUR HERSTELLUNG VON (6R,10S)-10-{4-[5-CHLOR-2-(4-CHLOR-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-1(6H)- PYRIMIDINYL}-1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOLO [4,3-B] [1,7] DIAZACYCLOTETRADECIN-5(6H)-ON |
| 51 | IPC main class | ICM
(ICMV) | C07D 213/61 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | C07D 401/04 (2006.01), C07D 471/18 (2006.01) |
| 22 | DE application date | DAT | Apr 10, 2020 |
| 96 | EP application date | EAT | Apr 10, 2020 |
| 86 | WO application date | WAT | Apr 10, 2020 |
| 43 | Date of first publication | OT | Oct 15, 2020 |
| Date of publication of grant | PET | Nov 22, 2023 |
| 71/73 | Applicant/owner | INH | Bristol-Myers Squibb Company, Princeton, NJ, US; Janssen Pharmaceutica NV, Beerse, BE |
| 72 | Inventor | IN | CUNIERE, Nicolas, Princeton, New Jersey 08543, US; FAN, Yu, Highland Park, New Jersey 08904, US; KOLOTUCHIN, Sergei, Princeton, New Jersey 08543, US; MUKHERJEE, Subha, Princeton, New Jersey 08543, US; SIMMONS, Eric M., Princeton, New Jersey 08543, US; SINGH, Amarjit, Highland Park, New Jersey 08904, US; WEI, Carolyn S., Princeton, New Jersey 08543, US; XIAO, Yi, Princeton, New Jersey 08543, US; YUAN, Changxia, Princeton, New Jersey 08543, US; ZHENG, Bin, Princeton, New Jersey 08543, US; WAGSCHAL, Simon Albert, 8200 Schaffhausen, CH; BROGGINI, Diego Fernando Domenico, 8200 Schaffhausen, CH; CAO, Duy Chi Trung, 8200 Schaffhausen, CH; CHERNICHENKO, Kostiantyn, 2340 Beerse, BE; LEMAIRE, Sébastien François Emmanuel, 2340 Beerse, BE; BEN HAIM, Cyril, 2340 Beerse, BE |
| Address for service | | Marks & Clerk LLP, 1017 Luxembourg, LU |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
201962832614 P
Apr 11, 2019
|
| Due date | FT
FG | Apr 30, 2026
Annual fee for the 7th year
Patent fees |
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003953334A1
Searchable text:
EP000003953334A1
Original document:
EP000003953334B1
Searchable text:
EP000003953334B1
Original document:
WO002020210613
Searchable text:
WO002020210613 |
| 43 | Date of first publication | EVT | Oct 15, 2020 |
| Date of the first transfer into DPMAregister | EREGT | Feb 16, 2022 |
| Date of the (most recent) update in DPMAregister | REGT | May 7, 2025
(Show all update days)(Hide all update days)- May 7, 2025
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 22.11.2023: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 22.11.2023: deleted
- Mar 15, 2025
- Nov 14, 2024
- Procedures: Procedure relating to EP application, Grant has become final, 23.08.2024: changed
- Oct 10, 2024
- Procedures: Procedure relating to EP application, Grant has become final, 23.08.2024: new
- Jul 25, 2024
- St.36: changed (technical change)
- May 2, 2024; Mar 13, 2024; Nov 29, 2023; Oct 27, 2023; Oct 26, 2023
- Historical data not available for this/these date(s)
- Feb 16, 2022
- Date of the first transfer into DPMAregister
|
